# HCI Group, Inc.: financial statements, quarterly

HCI · NYSE · CIK 1400810 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hci.md) · [Financials](/companies/hci/financials.md) · [Filings](/companies/hci/filings.md) · [Insiders](/companies/hci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [132](/filings/0001193125-26-076743.md) | [163](/filings/0001193125-26-076743.md) | [207](/filings/0001193125-26-076743.md) | [206](/filings/0001193125-26-076743.md) | [175](/filings/0001193125-26-076743.md) | [162](/filings/0001193125-26-076743.md) | [216](/filings/0001193125-26-211993.md) | [222](/filings/0001193125-26-340280.md) | [216](/filings/0001193125-26-076743.md) | [246](/filings/0001193125-26-076743.md) | [243](/filings/0001193125-26-211993.md) | [247](/filings/0001193125-26-340280.md) |
| Interest expense | $m | [2.8](/filings/0000950170-23-061081.md) | [(8.1) d](/filings/0000950170-25-029999.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.4](/filings/0000950170-24-124033.md) | [13.2 d](/filings/0001193125-26-076743.md) | [20.5](/filings/0000950170-25-067975.md) | [18.9](/filings/0000950170-25-105801.md) | [4.7](/filings/0001193125-25-272275.md) | [1.8 d](/filings/0001193125-26-076743.md) | [26.1](/filings/0001193125-26-211993.md) | [24.1](/filings/0001193125-26-340280.md) | [22.7](/filings/0001193125-25-272275.md) | [36.0 d](/filings/0001193125-26-076743.md) | [30.3](/filings/0001193125-26-211993.md) | [28.1](/filings/0001193125-26-340280.md) |
| Net income | $m | [13.2](/filings/0000950170-24-124033.md) | [40.9](/filings/0001193125-26-076743.md) | [47.6](/filings/0000950170-25-067975.md) | [54.1](/filings/0000950170-25-105801.md) | [5.7](/filings/0001193125-25-272275.md) | [4.1](/filings/0001193125-26-076743.md) | [69.7](/filings/0001193125-26-211993.md) | [66.2](/filings/0001193125-26-340280.md) | [65.5](/filings/0001193125-25-272275.md) | [108](/filings/0001193125-26-076743.md) | [73.4](/filings/0001193125-26-211993.md) | [73.8](/filings/0001193125-26-340280.md) |
| Diluted EPS | $ per share | [1.34](/filings/0001193125-26-076743.md) | [3.40](/filings/0001193125-26-076743.md) | [3.81](/filings/0001193125-26-076743.md) | [4.24](/filings/0001193125-26-076743.md) | [0.52](/filings/0001193125-26-076743.md) | [0.23](/filings/0001193125-26-076743.md) | [5.35](/filings/0001193125-26-211993.md) | [5.18](/filings/0001193125-26-340280.md) | [4.90](/filings/0001193125-26-076743.md) | [7.25](/filings/0001193125-26-076743.md) | [5.45](/filings/0001193125-26-211993.md) | [5.60](/filings/0001193125-26-340280.md) |
| Basic EPS | $ per share | [1.53](/filings/0001193125-26-076743.md) | [4.31](/filings/0001193125-26-076743.md) | [4.76](/filings/0001193125-26-076743.md) | [5.18](/filings/0001193125-26-076743.md) | [0.54](/filings/0001193125-26-076743.md) | [0.24](/filings/0001193125-26-076743.md) | [6.47](/filings/0001193125-26-211993.md) | [5.57](/filings/0001193125-26-340280.md) | [5.05](/filings/0001193125-26-076743.md) | [7.50](/filings/0001193125-26-076743.md) | [5.62](/filings/0001193125-26-211993.md) | [5.78](/filings/0001193125-26-340280.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [324](/filings/0000950170-23-061081.md) | [536](/filings/0000950170-25-029999.md) | [655](/filings/0000950170-24-056839.md) | [446](/filings/0000950170-24-094718.md) | [519](/filings/0000950170-24-124033.md) | [532](/filings/0001193125-26-076743.md) | [754](/filings/0000950170-25-067975.md) | [947](/filings/0000950170-25-105801.md) | [988](/filings/0001193125-25-272275.md) | [1,210](/filings/0001193125-26-340280.md) | [1,014](/filings/0001193125-26-211993.md) | [872](/filings/0001193125-26-340280.md) |
| Total assets | $m | [1,724](/filings/0000950170-23-061081.md) | [1,811](/filings/0000950170-25-029999.md) | [1,842](/filings/0000950170-24-056839.md) | [1,911](/filings/0000950170-24-094718.md) | [1,987](/filings/0000950170-24-124033.md) | [2,230](/filings/0001193125-26-076743.md) | [2,307](/filings/0000950170-25-067975.md) | [2,353](/filings/0000950170-25-105801.md) | [2,347](/filings/0001193125-25-272275.md) | [2,529](/filings/0001193125-26-340280.md) | [2,611](/filings/0001193125-26-211993.md) | [2,648](/filings/0001193125-26-340280.md) |
| Total liabilities | $m | [1,429](/filings/0000950170-23-061081.md) | [1,388](/filings/0000950170-25-029999.md) | [1,444](/filings/0000950170-24-056839.md) | [1,457](/filings/0000950170-24-094718.md) | [1,519](/filings/0000950170-24-124033.md) | [1,761](/filings/0001193125-26-076743.md) | [1,762](/filings/0000950170-25-067975.md) | [1,566](/filings/0000950170-25-105801.md) | [1,491](/filings/0001193125-25-272275.md) | [1,414](/filings/0001193125-26-340280.md) | [1,433](/filings/0001193125-26-211993.md) | [1,469](/filings/0001193125-26-340280.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [200](/filings/0000950170-23-061081.md) | [325](/filings/0000950170-25-029999.md) | [396](/filings/0000950170-24-056839.md) | [447](/filings/0000950170-24-094718.md) | [455](/filings/0000950170-24-124033.md) | [453](/filings/0001193125-26-076743.md) | [523](/filings/0000950170-25-067975.md) | [759](/filings/0000950170-25-105801.md) | [822](/filings/0001193125-25-272275.md) | [1,041](/filings/0001193125-26-340280.md) | [1,089](/filings/0001193125-26-211993.md) | [1,080](/filings/0001193125-26-340280.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [71.4 d](/filings/0000950170-24-124033.md) | [153 d](/filings/0001193125-26-076743.md) | [182](/filings/0000950170-25-067975.md) | [(29.0) d](/filings/0000950170-25-105801.md) | [104 d](/filings/0001193125-25-272275.md) | [74.7 d](/filings/0001193125-26-076743.md) | [162](/filings/0001193125-26-211993.md) | [145 d](/filings/0001193125-26-340280.md) | [26.7 d](/filings/0001193125-25-272275.md) | [111 d](/filings/0001193125-26-076743.md) | [149](/filings/0001193125-26-211993.md) | [125 d](/filings/0001193125-26-340280.md) |
| Capital expenditure | $m | [2.4 d](/filings/0000950170-24-124033.md) | [1.3 d](/filings/0001193125-26-076743.md) | [0.9](/filings/0000950170-25-067975.md) | [1.1 d](/filings/0000950170-25-105801.md) | [1.0 d](/filings/0001193125-25-272275.md) | [1.1 d](/filings/0001193125-26-076743.md) | [1.7](/filings/0001193125-26-211993.md) | [0.5 d](/filings/0001193125-26-340280.md) | [0.8 d](/filings/0001193125-25-272275.md) | [0.6 d](/filings/0001193125-26-076743.md) | [0.3](/filings/0001193125-26-211993.md) | [0.3 d](/filings/0001193125-26-340280.md) |
| Dividends paid | $m | [3.4 d](/filings/0000950170-24-124033.md) | [3.4 d](/filings/0001193125-26-076743.md) | [4.0](/filings/0000950170-25-067975.md) | [4.2 d](/filings/0000950170-25-105801.md) | [4.2 d](/filings/0001193125-25-272275.md) | [4.2 d](/filings/0001193125-26-076743.md) | [4.3](/filings/0001193125-26-211993.md) | [4.6 d](/filings/0001193125-26-340280.md) | [5.2 d](/filings/0001193125-25-272275.md) | [5.2 d](/filings/0001193125-26-076743.md) | [5.2](/filings/0001193125-26-211993.md) | [5.1 d](/filings/0001193125-26-340280.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-124033.md) | [0.0 d](/filings/0001193125-26-076743.md) | [0.6](/filings/0000950170-25-067975.md) | [0.5 d](/filings/0000950170-25-105801.md) | [0.0 d](/filings/0001193125-25-272275.md) | [0.0 d](/filings/0001193125-26-076743.md) | [0.0](/filings/0001193125-26-211993.md) | [0.0 d](/filings/0001193125-26-340280.md) | [0.7 d](/filings/0001193125-25-272275.md) | [0.8 d](/filings/0001193125-26-076743.md) | [17.5](/filings/0001193125-26-211993.md) | [57.0 d](/filings/0001193125-26-340280.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [8.4](/filings/0000950170-23-061081.md) | [0.0](/filings/0000950170-24-056839.md) | [0.0](/filings/0000950170-24-094718.md) | [0.0](/filings/0000950170-24-124033.md) | [12.6](/filings/0000950170-25-067975.md) | [12.7](/filings/0000950170-25-105801.md) | [10.5](/filings/0001193125-25-272275.md) | [12.8](/filings/0001193125-26-211993.md) | [12.9](/filings/0001193125-26-340280.md) | [12.9](/filings/0001193125-25-272275.md) | [12.9](/filings/0001193125-26-211993.md) | [12.7](/filings/0001193125-26-340280.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,438,867 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340280.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.